Jim Simons Zomedica Corp. Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.19 - $0.22 $11,176 - $12,940	58,822 New	58,822 $12,000
Q4 2022 Feb 13, 2023	SELL	$0.16 - $0.25 $142,320 - $222,375	-889,500 Reduced 87.59%	126,000 $21,000
Q3 2022 Nov 14, 2022	SELL	$0.2 - $0.38 $298,400 - $566,960	-1,492,000 Reduced 59.5%	1,015,500 $214,000
Q2 2022 Aug 12, 2022	BUY	$0.2 - $0.34 $501,500 - $852,550	2,507,500 New	2,507,500 $552,000
Q3 2021 Nov 12, 2021	SELL	$0.46 - $0.81 $6.15 Million - $10.8 Million	-13,371,960 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$0.72 - $1.46 $9.63 Million - $19.5 Million	13,371,960 New	13,371,960 $11.1 Million

80.9M

Ticker ZOM
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 979,950,016
Market Cap $127M
Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.